2013 Competition Physicians 
Scott’s Directories
APRIL 30, 2022
The healthcare industry is pretty competitive, recording massive growth yearly. Here are some developments in B2B healthcare marketing that can help stay competitive in the healthcare industry. In fact, a study in 2013 by Google and HIMSS showed that 50% of hospital administrators research products they need on the internet.
Clarivate
APRIL 24, 2023
CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
OCTOBER 5, 2022
As per the US Department of Justice, Biogen paid remuneration in the form of training and consulting fees and speaker honoraria, to induce physicians to prescribe the company’s drugs, in violation of the Anti-Kickback Statute. More recently, Biogen has been facing competition from dimethyl fumarate generics.
PM360
MAY 15, 2023
The EHR is the Holy Grail of POC Messaging (At Least for Now) Reaching HCPs while they’re prescribing is the epitome of physician messaging. The Point of Care Marketing Association (POCMA) is the Go-to Source for POC Education/Advocacy Founded in 2013, POCMA supports the POC channel through education and advocacy.
Pharmaceutical Technology
OCTOBER 25, 2022
Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.
European Pharmaceutical Review
NOVEMBER 8, 2022
For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. Actavis, 570 U.S.
Clarivate
APRIL 18, 2024
Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Michelle La Vone has been with Clarivate Market Access Insights (formerly Decision Resources Group) since 2013. The post How retailers and “payviders” are disrupting U.S.
Expert insights. Personalized for you.
40 
Let's personalize your content